Clinical Research FDA Approval Pharma Companies Regulation 
Find Me Cure
SEPTEMBER 2, 2020
As part of our patient advocacy efforts, at FindMeCure we are dedicated to creating a bridge between patients and the world of clinical research. This includes spreading clinical trial awareness, connecting patients to the trials they are interested in but also speaking up about the issues in the clinical research industry. .
pharmaphorum
JULY 8, 2022
“They can solve some immediate challenges with participation in research by conducting eCOA (electronic clinical outcome assessment) remotely or doing virtual visits. We have also seen the regulators actively support the use of these hybrid decentralised research approaches. Novel digital endpoints.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
AUGUST 31, 2021
Christopher Boone, global head of health economics and outcomes research at AbbVie, advises: “Evidence generation in drug development is ripe for innovation in the digital era and the expanded use of real-world evidence presents a clear enabler to saving time and money. It is true that RWD contains more potential bias as a result.
pharmaphorum
DECEMBER 21, 2021
However, despite the work still left to be done, there are now a growing number of treatments in the pipeline and 2020 proved to be a remarkable year for orphan drug approvals, with the US FDA approving more orphan designated treatments than non-orphan drugs. Headway being made. The potential to leverage genomic data.
Cloudbyz
MAY 19, 2021
increase in CGT clinical trials. Segregation of cell and gene therapy conducted during 2020, based on clinical trial phases (Source: Alliance for Regenerative Medicine ) As of date, the FDA approved only 7 cell and gene therapy drugs, however, the product pipeline included ~1,200 experimental therapies.
Expert insights. Personalized for you.
97 
Let's personalize your content